{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:36:11Z","timestamp":1782779771701,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA225753"],"award-info":[{"award-number":["U01 CA225753"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R50 CA221808"],"award-info":[{"award-number":["R50 CA221808"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01 CA160254"],"award-info":[{"award-number":["1R01 CA160254"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.clinre.2019.12.010","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T16:07:32Z","timestamp":1579363652000},"page":"681-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Valentina","family":"Peta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lubman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Imbert-Bismutd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Bolbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Clodic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucr\u00e8ce","family":"Matheron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pais","family":"Raluca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Housset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Rezai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Poynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2019.12.010_bib0220","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.02.049","article-title":"Surveillance for HCC: current best practice and future direction","author":"Kanwal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2019.12.010_bib0225","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","article-title":"Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012","volume":"152","author":"White","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2019.12.010_bib0230","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2019.12.010_bib0235","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"E.A.S.L.","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.12.010_bib0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/CMO.S9926","article-title":"Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics","volume":"8","author":"Flores","year":"2014","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.clinre.2019.12.010_bib0245","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bmj.2.5918.527","article-title":"Serum alpha-fetoprotein: diagnostic significance in liver disease","volume":"2","author":"Ruoslahti","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.clinre.2019.12.010_bib0250","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7","article-title":"Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B","volume":"64","author":"Di Bisceglie","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.clinre.2019.12.010_bib0255","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2019.12.010_bib0260","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2014.11.005","article-title":"Performance of DCP for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion","volume":"62","author":"Pot\u00e9","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.12.010_bib0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinre.2019.12.010_bib0270","doi-asserted-by":"crossref","first-page":"e94536","DOI":"10.1371\/journal.pone.0094536","article-title":"Decreased core-fucosylation contributes to malignancy in gastric cancer","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"8.","key":"10.1016\/j.clinre.2019.12.010_bib0275","article-title":"Relationship between increased fucosylation and metastatic potential in colorectal cancer","volume":"108","author":"Osuga","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.010_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biom2010034","article-title":"Fucosylation is a promising target for cancer diagnosis and therapy","volume":"2","author":"Miyoshi","year":"2012","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.clinre.2019.12.010_bib0285","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3748\/wjg.v19.i3.339","article-title":"Diagnostic value of AFP-L3 and DCP in hepatocellular carcinoma according to total-AFP","volume":"19","author":"Choi","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2019.12.010_bib0290","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1039\/c1mb05020f","article-title":"N-linked glycan changes of serum haptoglobin beta chain in liver disease patients","volume":"7","author":"Zhang","year":"2011","journal-title":"Mol BioSyst"},{"issue":"17","key":"10.1016\/j.clinre.2019.12.010_bib0295","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/elps.201700025","article-title":"LC-MS\/MS isomeric profiling of permethylated N-glycan derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients","volume":"38","author":"Huang","year":"2017","journal-title":"Electrophoresis"},{"issue":"12","key":"10.1016\/j.clinre.2019.12.010_bib0300","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1021\/acs.jproteome.5b00792","article-title":"ESI-LC-MS method for haptoglobin fucosylation analysis in hepatocellular carcinoma and liver cirrhosis","volume":"14","author":"Zhang","year":"2015","journal-title":"J Proteome Res"},{"issue":"6","key":"10.1016\/j.clinre.2019.12.010_bib0305","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1021\/pr500128t","article-title":"Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies","volume":"13","author":"Zhu","year":"2014","journal-title":"J Proteome Res"},{"issue":"3","key":"10.1016\/j.clinre.2019.12.010_bib0310","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/apt.15082","article-title":"LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis","volume":"49","author":"Poynard","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2019.12.010_bib0315","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/gm493","article-title":"Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury","volume":"5","author":"Borlak","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/j.clinre.2019.12.010_bib0320","doi-asserted-by":"crossref","first-page":"e0189436","DOI":"10.1371\/journal.pone.0189436","article-title":"Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery","volume":"12","author":"Peta","year":"2017","journal-title":"PlosOne"},{"key":"10.1016\/j.clinre.2019.12.010_bib0325","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5582\/ddt.2016.01052","article-title":"Advances of diagnostic and mechanistic studies of \u03b3-glutamyl transpeptidase in hepatocellular carcinoma","volume":"10","author":"Xia","year":"2016","journal-title":"Drug Discov Ther"},{"issue":"4","key":"10.1016\/j.clinre.2019.12.010_bib0330","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2013.11.016","article-title":"Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTestTM) and transient elastography (FibroScan\u00ae)","volume":"60","author":"Poynard","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.010_bib0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.13446","article-title":"Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B","volume":"43","author":"Houot","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2019.12.010_bib0340","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clinre.2019.12.010_bib0345","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1021\/acs.jproteome.5b00662","article-title":"Mass spectrometric N-glycan analysis of haptoglobin from patient serum samples using a 96-well plate format","volume":"14","author":"Zhu","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clinre.2019.12.010_bib0350","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1021\/pr500128t","article-title":"Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies","volume":"13","author":"Zhu","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clinre.2019.12.010_bib0355","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1002\/rcm.2210","article-title":"Solidphase permethylation of glycan for mass spectrometric analysis","volume":"19","author":"Kang","year":"2005","journal-title":"Rapid Commun. Mass Spectrom"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.010_bib0360","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2019.12.010_bib0365","series-title":"NCSS 2011 user guide. Number cruncher statistical systems software","author":"Hintze","year":"2011"},{"issue":"5","key":"10.1016\/j.clinre.2019.12.010_bib0370","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.dld.2009.09.002","article-title":"Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal","volume":"42","author":"Trevisani","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2019.12.010_bib0375","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2019.12.010_bib0380","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.12.010_bib0385","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/pmic.200800163","article-title":"Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation","volume":"16","author":"Arnold","year":"2008","journal-title":"Proteomics"},{"issue":"8","key":"10.1016\/j.clinre.2019.12.010_bib0390","doi-asserted-by":"crossref","first-page":"e12419","DOI":"10.1371\/journal.pone.0012419","article-title":"Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma","volume":"5","author":"Comunale","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2019.12.010_bib0395","doi-asserted-by":"crossref","first-page":"35478","DOI":"10.18632\/oncotarget.8155","article-title":"Hallmarks of glycosylation in cancer","volume":"7","author":"Munkley","year":"2016","journal-title":"Oncotarget"},{"issue":"9262","key":"10.1016\/j.clinre.2019.12.010_bib0400","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clinre.2019.12.010_bib0405","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jhep.2014.06.027","article-title":"Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest\u00ae) and elastography (FibroScan\u00ae)","volume":"61","author":"Poynard","year":"2014","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2019.12.010_bib0410","doi-asserted-by":"crossref","first-page":"e100182","DOI":"10.1371\/journal.pone.0100182","article-title":"The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clinre.2019.12.010_bib0415","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","article-title":"Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease","volume":"154","author":"Thiele","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2019.12.010_bib0420","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.22576","article-title":"Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease","volume":"49","author":"Naveau","year":"2009","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.clinre.2019.12.010_bib0425","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.13770","article-title":"Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference","volume":"44","author":"Munteanu","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.clinre.2019.12.010_bib0430","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/apt.14990","article-title":"Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease","volume":"48","author":"Munteanu","year":"2018","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119302724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119302724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:29:36Z","timestamp":1761895776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740119302724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2210740119302724"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2019.12.010","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2019.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}